Nuveen Asset Management, LLC - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 49 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 2.4%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$667,455
-67.0%
623,790
-20.2%
0.00%
-100.0%
Q2 2023$2,023,663
+64409.5%
781,337
+1.6%
0.00%0.0%
Q1 2023$3,137
-17.5%
768,884
+1.5%
0.00%0.0%
Q4 2022$3,803
-100.0%
757,753
+2.6%
0.00%
-75.0%
Q3 2022$9,664,000
+40.8%
738,810
+38.0%
0.00%
+33.3%
Q2 2022$6,864,000
+82.9%
535,438
+116.8%
0.00%
+200.0%
Q1 2022$3,752,000
-17.2%
247,026
-3.4%
0.00%0.0%
Q4 2021$4,529,000
+11.8%
255,760
+45.4%
0.00%0.0%
Q3 2021$4,052,000
+65.5%
175,936
+41.7%
0.00%0.0%
Q2 2021$2,449,000
-51.2%
124,163
-28.1%
0.00%
-50.0%
Q1 2021$5,020,000
+65.8%
172,676
+72.7%
0.00%
+100.0%
Q4 2020$3,028,000
+102.8%
99,980
+6.5%
0.00%0.0%
Q3 2020$1,493,000
-32.5%
93,837
-16.3%
0.00%0.0%
Q2 2020$2,213,000
+56.8%
112,118
-2.0%
0.00%0.0%
Q1 2020$1,411,000
-65.7%
114,438
-48.6%
0.00%
-50.0%
Q4 2019$4,113,000
+1146.4%
222,469
+833.4%
0.00%
Q3 2019$330,000
+124.5%
23,834
+138.0%
0.00%
Q2 2019$147,00010,0160.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Column Group LLC 18,136,735$232,513,00049.48%
Ponoi II Management, LLC 1,298,908$16,652,00045.25%
Ponoi Management, LLC 1,298,908$16,652,00026.29%
Euclidean Capital LLC 746,674$9,572,0008.14%
StepStone Group LP 1,573,357$20,170,0002.16%
First Light Asset Management, LLC 1,135,884$14,562,0001.69%
Lexington Partners L.P. 110,428$1,416,0000.73%
Rubric Capital Management LP 797,588$10,225,0000.54%
Boxer Capital, LLC 500,000$6,410,0000.41%
DAFNA Capital Management LLC 107,653$1,380,0000.38%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders